- Your cart is empty
- Continue Shopping
APOE Genotype Interpretation Guide
APO E has the Strongest Genetic Associations with Alzheimer’s Disease
The Genetic basis of Alzheimer’s disease is relatively complex. There are a variety of inherited familial conditions associated with high risk for developing Alzheimer’s dementia. However, when considering non-familial Alzheimer’s disease and dementia, Apo E has the greatest predictive value.
The Apo E4 allele remains the strongest genetic risk factor for non-familial Alzheimer’s and Apo E2 allele remains the greatest protective risk factor. Newer data even suggests therapies targeting Apo E4 may be used either to reduce risk or for treatment.
Apolipoprotein E (APOE) is a gene that provides instructions for making a protein called apolipoprotein E, which plays a crucial role in the metabolism of lipids (fats) in the body. APOE comes in different genetic variations known as genotypes, and these genotypes have been associated with various health outcomes, particularly in relation to cardiovascular and neurological diseases. Below is an interpretation guide for the three most common APOE genotypes:
Interpretation Guide for Apolipoprotein E Genotypes
APOE ε2/ε2:
Homozygous for the ε2 allele.
This genotype is the least common among the general population.
APOE ε2/ε2 is considered the most protective against developing Alzheimer’s disease (a type of dementia).
Individuals with this genotype tend to have lower levels of cholesterol and may have a reduced risk of cardiovascular diseases.
APOE ε2/ε2:
Homozygous for the ε2 allele.
This is the most common genotype in the general population.
APOE ε2/ε2 is considered the most protective against developing Alzheimer’s disease (a type of dementia).
Individuals with this genotype tend to have lower levels of cholesterol and may have a reduced risk of cardiovascular diseases.
APOE ε4/ε4:
Homozygous for the ε4 allele.
This is the most common genotype in the general population.
APOE ε2/ε2 is considered the most protective against developing Alzheimer’s disease (a type of dementia).
Individuals with this genotype tend to have lower levels of cholesterol and may have a reduced risk of cardiovascular diseases.
It’s important to note that while APOE genotyping can provide some insight into an individual’s risk for certain diseases, it is not a definitive predictor. Other genetic and environmental factors also play a significant role in disease development. Furthermore, APOE genotyping should only be used for medical purposes under the guidance of a healthcare professional or genetic counselor.
